The Canadian Cancer Trials Group
@cctg.bsky.social
The Canadian Cancer Trials Group (CCTG) is an academic cooperative oncology group that designs and conducts clinical trials testing cancer therapy, supportive care and prevention interventions across Canada.
Reminder that this Friday (Nov 14th) we #YGK welcome Dr Désy as our special guest speaker discussing Soul Healing: Practicing Medicine in Rural Northern Communities and Building
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE
November 12, 2025 at 12:12 PM
Reminder that this Friday (Nov 14th) we #YGK welcome Dr Désy as our special guest speaker discussing Soul Healing: Practicing Medicine in Rural Northern Communities and Building
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE
#RemembranceDay - Today we remember and pay tribute to the Canadian armed forces members who have died in the line of duty. #CCTG honours everyone who continues to serve and who defend our values and freedoms. #LestWeForget
November 11, 2025 at 3:45 PM
#RemembranceDay - Today we remember and pay tribute to the Canadian armed forces members who have died in the line of duty. #CCTG honours everyone who continues to serve and who defend our values and freedoms. #LestWeForget
November is #Neuroendocrine (#NET) Cancer Awareness Month. Today CCTG supports World #NETCancerDay to raise awareness for this often-misdiagnosed cancer. Trials like NE2 (STOPNET) are looking to improve outcomes for these patients #LetsTalkAboutNETs buff.ly/mE3LstH
November 10, 2025 at 1:02 PM
November is #Neuroendocrine (#NET) Cancer Awareness Month. Today CCTG supports World #NETCancerDay to raise awareness for this often-misdiagnosed cancer. Trials like NE2 (STOPNET) are looking to improve outcomes for these patients #LetsTalkAboutNETs buff.ly/mE3LstH
The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S
November 6, 2025 at 1:01 PM
The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S
#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ
November 5, 2025 at 1:01 PM
#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ
November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M
November 4, 2025 at 12:30 PM
November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M
#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...
October 31, 2025 at 11:32 AM
#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...
A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years.
buff.ly/CfRbmSE
buff.ly/CfRbmSE
October 24, 2025 at 3:11 PM
A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years.
buff.ly/CfRbmSE
buff.ly/CfRbmSE
Thanks to the #CCTG sites and #breastcancer patients who participated, making Canada one of the top 10 accruing countries globally. Showing that it is possible to have a temporary interruption of endocrine therapy to permit pregnancy. @cancersociety.bsky.social @ccsresearch.bsky.social
#ESMO25 The latest results from the #POSITIVE study show that temporary interruption of #endocrinetherapy for pregnancy does not add risk of #breastcancer recurrence at 6 yrs median FU. Most pts resumed ET per protocol. @etop_ibcsg @OncoAlert @oncodaily
October 20, 2025 at 6:01 PM
Thanks to the #CCTG sites and #breastcancer patients who participated, making Canada one of the top 10 accruing countries globally. Showing that it is possible to have a temporary interruption of endocrine therapy to permit pregnancy. @cancersociety.bsky.social @ccsresearch.bsky.social
Results from the primary analysis of the ctDNA-negative cohort from the international DYNAMIC-III (CO29) colon cancer clinical trial were presented at the #ESMO25 Presidential Symposium and simultaneously published in #NatureMagazine. @agitg @petermaccc @ccsresearch @cancersociety buff.ly/YeYWTde
October 20, 2025 at 5:34 PM
Results from the primary analysis of the ctDNA-negative cohort from the international DYNAMIC-III (CO29) colon cancer clinical trial were presented at the #ESMO25 Presidential Symposium and simultaneously published in #NatureMagazine. @agitg @petermaccc @ccsresearch @cancersociety buff.ly/YeYWTde
Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.
October 20, 2025 at 3:25 PM
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...
October 20, 2025 at 12:47 PM
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...
The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y
October 10, 2025 at 12:03 PM
The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y
#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI
October 9, 2025 at 12:15 PM
#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI
The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > buff.ly/MZzXJI1 buff.ly/MZzXJI1
October 8, 2025 at 12:02 PM
The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > buff.ly/MZzXJI1 buff.ly/MZzXJI1
The Canadian Cancer Trials Group #CCTG is currently seeking applications for a Patient Representative to support the #Gastrointestinal Disease Site Committee. Find out more > buff.ly/kgWqbn7
October 7, 2025 at 12:45 PM
The Canadian Cancer Trials Group #CCTG is currently seeking applications for a Patient Representative to support the #Gastrointestinal Disease Site Committee. Find out more > buff.ly/kgWqbn7
October is #LiverCancerAwarenessMonth and the #CCTG HE2 trial researchers want to know if the combination of three common drugs used to treat #livercancer can offer better results than the standard treatment. buff.ly/Laeecvk
October 6, 2025 at 4:31 PM
October is #LiverCancerAwarenessMonth and the #CCTG HE2 trial researchers want to know if the combination of three common drugs used to treat #livercancer can offer better results than the standard treatment. buff.ly/Laeecvk
Come join the #CCTG team - apply today for the position of Human Resources and Staffing Operations Leader, responsible for a range of Human Resources and Staffing activities in support of the administration and operation of the group.
buff.ly/iSuoC3n
buff.ly/iSuoC3n
Queen's University Human Resources and Equity Careers | Human Resources and Staffing Operations Leader | Kingston, , Canada
Reporting to the Chief Operating Officer (COO), with accountability to the CCTG Director for Faculty staffing, the Human Resources and Staffing Operations Leader will lead the Human Resources and…
queensu.njoyn.com
October 3, 2025 at 1:05 PM
Come join the #CCTG team - apply today for the position of Human Resources and Staffing Operations Leader, responsible for a range of Human Resources and Staffing activities in support of the administration and operation of the group.
buff.ly/iSuoC3n
buff.ly/iSuoC3n
October is #BreastCancerAwarenessMonth and the #CCTG MAC27 trial is investigating if the combination of a new drug and a commonly used drug is better at preventing HER2-positive #breastcancer from returning #BreastCancerCanada, #BCAM, #PinkForBreastCancer buff.ly/X6OHJjN
October 1, 2025 at 11:30 AM
October is #BreastCancerAwarenessMonth and the #CCTG MAC27 trial is investigating if the combination of a new drug and a commonly used drug is better at preventing HER2-positive #breastcancer from returning #BreastCancerCanada, #BCAM, #PinkForBreastCancer buff.ly/X6OHJjN
National Day for Truth and Reconciliation: CCTG acknowledges the intergenerational impacts of residential schools & colonization. We are committed to reconciliation - designing and conducting trials that are equitable, culturally safe, & accessible for all First Nations, Inuit, & Métis peoples.
September 30, 2025 at 11:01 AM
National Day for Truth and Reconciliation: CCTG acknowledges the intergenerational impacts of residential schools & colonization. We are committed to reconciliation - designing and conducting trials that are equitable, culturally safe, & accessible for all First Nations, Inuit, & Métis peoples.
#CCTG trial spotlight for #LeukemiaAwarenessMonth & #ChildhoodCancerAwarenessMonth: The ALC6 study is testing if adding another drug to standard treatment improves outcomes for young adults with newly diagnosed B-cell acute lymphoblastic leukemia.
#myeloMATCH
Trial Info -> buff.ly/TZ0YRC0
#myeloMATCH
Trial Info -> buff.ly/TZ0YRC0
September 29, 2025 at 11:45 AM
#CCTG trial spotlight for #LeukemiaAwarenessMonth & #ChildhoodCancerAwarenessMonth: The ALC6 study is testing if adding another drug to standard treatment improves outcomes for young adults with newly diagnosed B-cell acute lymphoblastic leukemia.
#myeloMATCH
Trial Info -> buff.ly/TZ0YRC0
#myeloMATCH
Trial Info -> buff.ly/TZ0YRC0
#CCTG Trial Highlight for #BloodCancerAwarenessMonth: The MY13 study is evaluating whether stopping injections after 18 months can maintain disease control and improve quality of life in older adults with multiple #myeloma.
#MultipleMyeloma #CancerResearch #CCTG
Trial Info -> buff.ly/X6EoYBI
#MultipleMyeloma #CancerResearch #CCTG
Trial Info -> buff.ly/X6EoYBI
September 28, 2025 at 11:45 AM
#CCTG Trial Highlight for #BloodCancerAwarenessMonth: The MY13 study is evaluating whether stopping injections after 18 months can maintain disease control and improve quality of life in older adults with multiple #myeloma.
#MultipleMyeloma #CancerResearch #CCTG
Trial Info -> buff.ly/X6EoYBI
#MultipleMyeloma #CancerResearch #CCTG
Trial Info -> buff.ly/X6EoYBI
Recognizing #GynecologicCancerAwarenessMonth CCTG VU2 trial - a study is to evaluate if specific testing of vulva cancer tissue removed by surgery provides useful information to decide if additional surgery is needed.
#GCAM #MoveTheMessage
Trial Info -> buff.ly/qmXEtyl
#GCAM #MoveTheMessage
Trial Info -> buff.ly/qmXEtyl
September 27, 2025 at 12:30 PM
Recognizing #GynecologicCancerAwarenessMonth CCTG VU2 trial - a study is to evaluate if specific testing of vulva cancer tissue removed by surgery provides useful information to decide if additional surgery is needed.
#GCAM #MoveTheMessage
Trial Info -> buff.ly/qmXEtyl
#GCAM #MoveTheMessage
Trial Info -> buff.ly/qmXEtyl
#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes.
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
September 26, 2025 at 11:15 AM
#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes.
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
September is #ChildhoodCancerAwarenessMonth. #CCTG is committed to advancing research and clinical trials that develop better outcomes for children and their families.
#CancerResearch #SolvingCancerTogether #ChildhoodCancer
#CancerResearch #SolvingCancerTogether #ChildhoodCancer
September 25, 2025 at 11:15 AM
September is #ChildhoodCancerAwarenessMonth. #CCTG is committed to advancing research and clinical trials that develop better outcomes for children and their families.
#CancerResearch #SolvingCancerTogether #ChildhoodCancer
#CancerResearch #SolvingCancerTogether #ChildhoodCancer